American Journal of Public Health, November, 2017. In a guest editorial by NCHR president Dr. Diana Zuckerman, she questions whether the FDA’s plan to get generic drugs on the market more quickly is enough to make prescription drugs – and health insurance—affordable.
Read More »Our Medical Journal Articles
Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health
The innovation of medical IT has the potential to save lives, but even a small “glitch” can harm patients. Our study found hundreds of recalls of flawed devices that affected millions of patients. Examples include electronic medical records that provide info about the wrong patient and “physician support” devices that miscalculate the dosage of medication. But the FDA is set to deregulate these devices.
Read More »A Major Shortcoming in the Public Health Legacy of the Obama Administration
American Journal of Public Health, December 16, 2016. The Obama Administration has been a strong voice for many public health issues, including tobacco control, childhood obesity, and reproductive health. The Affordable Care Act is also a major accomplishment. But, under the same administration, the FDA caved into political pressure by approving medical products based on lower standards of scientific evidence. What will happen going forward?
Read More »Screening for Lung Cancer: To Be or Not to Be Covered By Medicare?
Journal of Thoracic Imaging, January 2015. Advocates urge Medicare to cover the cost of screening, but the MEDCAC expresses their lack of confidence that the benefits would outweigh the risks.
Read More »More Data are Needed for Essure Hysteroscopic Sterilization Device
Between 2002, when Essure was approved by the FDA and December 2014, approximately 1500 reports of adverse reactions were reported to the FDA, including pregnancy, hemorrhage, pelvic pain, and menstrual irregularities.
Read More »